Company: ARTL
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001640334-25-001429
Chunk: 417

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 417
---
 638 Loss from Operations  (3,150)  (2,512)  (638)Other income  (71)  79   (150)Net Loss $(3,221) $(2,433) $(788)

 24Table of Contents

Our operating expenses for the three months ended June 30, 2025, were $3.2 million compared to $2.5 million for the same period in 2024. The increase in operating expenses for the three months ended June 30, 2025, was primarily the result of increases in professional fees associated with our capital raising efforts and increases in research and development expenditures related to our clinical programs. Offsetting the increased research and development expenditures were tax credits of $704 received from the UK Government during the current period compared to the credits in the prior year which were received subsequent to June 30, 2024.

Six months ended June 30, 2025, compared to the six months ended June 30, 2024

  Six months ended      June 30,    (In thousands) 2025  2024  Change Operating Expenses         General and administrative $2,274  $1,909  $365 Research and development  3,255   3,192   63 Total Operating Expenses  5,529   5,101   428 Loss from Operations  (5,529)  (5,101)  (428)Other income (expense)  (64)  185   (249)Net Loss $(5,593) $(4,916) $(677)

Our operating expenses for the six months ended June 30, 2025, were $5.5 million compared to $5.1 million for the same period in 2024. The increase in operating expenses for the six months ended June 30, 2025, was primarily the result of increases in professional fees associated with our capital raising efforts and increases in research and development expenditures related to our clinical programs. Offsetting the increased research and development expenditures were tax credits of $704 received from the UK Government during the current period compared to the credits in the prior year which were received subsequent to June 30, 2024.

Liquidity and Capital Resources

Sources of Liquidity

Liquidity is the ability of a company to generate funds